Diabetic retinopathy is a common complication of diabetes, which manifests as a potentially severe eye disease that can lead to permanent vision loss if not properly managed. Related: What does an A1C ...

Eye damage remains uncommon after 15 years, but certain factors increase the risk ...

Weight loss medications Mounjaro and Zepbound, which contain the active ingredient tirzepatide, may lower the risk of diabetic retinopathy.

Obesity, overweight, and hypertension could also affect the risk of retinopathy if not managed in patients. The Swedish National Diabetes Register was used to conduct the study and collect data on ...

Retinopathy of Prematurity is one of the leading causes of preventable blindness in children. Doctors say early screening and ...

For sura-vec in wet AMD, top line data from pivotal studies ATMOSPHERE and ASCENT are anticipated in Q4. First patient dosing in NAVIGATE for diabetic retinopathy is planned next quarter, expected to ...

Tirzepatide use is associated with a lower incidence of new or progressive diabetic retinopathy (DR) and fewer complications.

Empagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, did not reduce the risk for incident nonproliferative diabetic retinopathy compared with dipeptidyl peptidase 4 (DPP-4) inhibitors in ...